Ihuman Inc SEC Filings

Welcome to our dedicated page for Ihuman SEC filings (Ticker: IH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

When investors explore iHuman Inc’s reports, they usually start with two questions: how fast are subscription revenues for early-learning apps growing and how much do smart devices add to margins? Our SEC center anticipates that journey. The page opens with the latest iHuman Inc annual report 10-K simplified, where Stock Titan’s AI pinpoints segment revenue, user retention, and key Chinese regulatory notes—no need to wade through hundreds of pages.

Need quarterly detail? The iHuman Inc quarterly earnings report 10-Q filing is paired with an AI summary that extracts billings, ARPU trends, and R&D outlays for AI and AR features. Material updates arrive as soon as the company files; you’ll see iHuman Inc 8-K material events explained within minutes of hitting EDGAR.

Executive activity matters too. Track iHuman Inc Form 4 insider transactions real-time to see when founders adjust their stakes or exercise options. Our dashboard flags every iHuman Inc executive stock transactions Form 4 alongside historical charts, answering the common search “iHuman Inc insider trading Form 4 transactions”.

For governance questions such as teacher qualification disclosures or data-privacy oversight, open the proxy—labelled here as iHuman Inc proxy statement executive compensation—complete with AI commentary on pay structures and board risk discussions. Still learning how filings connect? Click the “understanding iHuman Inc SEC documents with AI” guide, or dive into our iHuman Inc earnings report filing analysis section to compare quarters instantly.

• AI-powered plain-language summaries
• Real-time filing alerts straight from EDGAR
• Coverage of every form—10-K, 10-Q, 8-K, 4, 13D/G and more

Complex disclosures about children’s data use or curriculum standards shouldn’t slow research. With iHuman Inc SEC filings explained simply, the insights are already surfaced, so you can focus on decisions, not document hunting.